- Home
- VEEE vs PMCB Comparison
VEEE vs PMCB Comparison
Compare VEEE & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- PMCB
- Stock Information
- Founded
- VEEE 1994
- PMCB 1996
- Country
- VEEE United States
- PMCB United States
- Employees
- VEEE N/A
- PMCB 2
- Industry
- VEEE Marine Transportation
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VEEE Industrials
- PMCB Health Care
- Exchange
- VEEE Nasdaq
- PMCB Nasdaq
- Market Cap
- VEEE 6.4M
- PMCB 7.3M
- IPO Year
- VEEE 2021
- PMCB N/A
- Fundamental
- Price
- VEEE $2.18
- PMCB $1.05
- Analyst Decision
- VEEE
- PMCB
- Analyst Count
- VEEE 0
- PMCB 0
- Target Price
- VEEE N/A
- PMCB N/A
- AVG Volume (30 Days)
- VEEE 851.0K
- PMCB 8.5K
- Earning Date
- VEEE 08-13-2025
- PMCB 08-12-2025
- Dividend Yield
- VEEE N/A
- PMCB N/A
- EPS Growth
- VEEE N/A
- PMCB N/A
- EPS
- VEEE N/A
- PMCB 1.29
- Revenue
- VEEE $12,724,465.00
- PMCB N/A
- Revenue This Year
- VEEE N/A
- PMCB N/A
- Revenue Next Year
- VEEE N/A
- PMCB N/A
- P/E Ratio
- VEEE N/A
- PMCB $0.82
- Revenue Growth
- VEEE N/A
- PMCB N/A
- 52 Week Low
- VEEE $2.05
- PMCB $1.00
- 52 Week High
- VEEE $9.30
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- VEEE 45.45
- PMCB 47.26
- Support Level
- VEEE $2.06
- PMCB $1.00
- Resistance Level
- VEEE $2.34
- PMCB $1.07
- Average True Range (ATR)
- VEEE 0.15
- PMCB 0.05
- MACD
- VEEE 0.02
- PMCB 0.01
- Stochastic Oscillator
- VEEE 33.03
- PMCB 39.78
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.